<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0253-570X</journal-id>
<journal-title><![CDATA[Revista de Salud Animal]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Salud Anim.]]></abbrev-journal-title>
<issn>0253-570X</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Sanidad Agropecuaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0253-570X2008000300003</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[OPTIMIZATION OF SCORING FUNCTION DOCKING FOR ANTIVIRAL DRUG DESIGN AGAINST CORONAVIRUS GENUS]]></article-title>
<article-title xml:lang="es"><![CDATA[OPTIMIZACIÓN DE LAS FUNCIONES DE PUNTUACIÓN DE DOCKING PARA EL DISEÑO DE FÁRMACOS ANTIVIRALES CONTRA EL GÉNERO CORONAVIRUS]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[L.J]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz de Arce]]></surname>
<given-names><![CDATA[Heidy]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro Nacional de Sanidad Agropecuaria (CENSA)  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2008</year>
</pub-date>
<volume>30</volume>
<numero>3</numero>
<fpage>160</fpage>
<lpage>165</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0253-570X2008000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0253-570X2008000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0253-570X2008000300003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The development of a wide-spectrum antiviral drug against pathogenic coronavirus is nowadays a attractive prospect and may provide an effective first line of defense against emerging CoV-related diseases. The most attractive target for the design of anticoronaviral inhibitors is the main protease or 3CL PRO. Ligand docking and screening algorithms are now frequently used in the drug-design process. The aim of this work based on a validation study of scoring functions is to find a consensus function or to select the scoring function that better predicts the orientation of the ligand in the pocket binding site, in order to perform a virtual screening in ligand databases, with a lower computational cost in the intent of finding a leader compound for antiviral drug against coronaviruses. For this purpose, the scoring functions were implemented within the Dock4.0 program suite and the 2ALV main protease three dimensional structures will be used. The protein structure was selected because it was crystallized with a non-peptidic ligand. The main protease coronavirus pocket including the catalytic dyad Cys145 His41 was obtained. The closer RSMD media values to 4.0 Aº were obtained using the contact score function from the rigid ligand dock method. This score function was selected as the best ranking tool for the search based on virtual screening of the potential candidate inhibitors of the important pathogen group belonging to the genus coronavirus.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[El desarrollo de fármacos antivirales de amplio espectro que se puedan utilizar contra diferentes patógenos emergentes del género coronavirus como primera línea de defensa es hoy una perspectiva atractiva. La proteasa principal de los coronavirus 3CL PRO es la diana de mayor atractivo para el diseño de inhibidores anticoronavirus. Los algoritmos de screening y docking son actualmente muy utilizados en los procesos de diseño racional de fármacos. El objetivo de este trabajo es, basados en un estudio de validación de las funciones de score, encontrar una función consenso o seleccionar la función de score que mejor prediga la orientación del ligando en el bolsillo catalítico de la 3CLpro, con el fin de mejorar las búsqueda por screening virtual en las bases de datos de ligandos, compuestos que puedan servir de líderes como candidatos a usarse como fármacos inhibidores anticoronavirus, con un menor costo computacional. Con este propósito se utilizaron las funciones de score implentadas en el paquete de programas del DOCK4.0 y la estructura cristalizada de la 3CLpro 2ALV, esta última se seleccionó por estar cristalizada con un ligando de naturaleza no peptídica. Se diseñó el bolsillo catalítico de la proteasa principal de coronavirus que incluyó los residuos que conforman la díada catalítica Cys145 His41. La función con la cual se obtuvieron los mejores valores de RSMD más cercanos a 4.0Aº, fue la función de contacto, siguiendo un algoritmo de orientación de ligando rígido, esta función se seleccionó como la mejor herramienta en la puntuación de búsquedas basadas en screening virtual de candidatos potenciales como inhibidores del importante grupo de patógenos del género coronavirus.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[docking algorithms]]></kwd>
<kwd lng="en"><![CDATA[scoring functions]]></kwd>
<kwd lng="en"><![CDATA[rigid docking]]></kwd>
<kwd lng="en"><![CDATA[flexible docking]]></kwd>
<kwd lng="en"><![CDATA[main protease]]></kwd>
<kwd lng="es"><![CDATA[algoritmos de docking]]></kwd>
<kwd lng="es"><![CDATA[funciones de puntuación]]></kwd>
<kwd lng="es"><![CDATA[docking rígido]]></kwd>
<kwd lng="es"><![CDATA[docking flexible]]></kwd>
<kwd lng="es"><![CDATA[proteasa principal]]></kwd>
<kwd lng="es"><![CDATA[coronavirus]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Trabajo    original</b></font></p>     <p>&nbsp;</p>     <p>&nbsp; </p> <H1> <font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="4">OPTIMIZATION    OF SCORING FUNCTION DOCKING FOR ANTIVIRAL DRUG DESIGN AGAINST CORONAVIRUS </font></B></font><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><B>GENUS</B>    </font></H1> <H1>&nbsp;</H1>     <p> <font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b><font size="3">OPTIMIZACI&Oacute;N    DE LAS FUNCIONES DE PUNTUACI&Oacute;N DE <i>DOCKING</i> PARA EL DISE&Ntilde;O    DE F&Aacute;RMACOS ANTIVIRALES CONTRA EL G&Eacute;NERO CORONAVIRUS </font></b></font>     <p>&nbsp;     <p>&nbsp;     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>L.J. P&eacute;rez    and Heidy D&iacute;az de Arce </B> </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><I>Centro Nacional    de Sanidad Agropecuaria (CENSA), Apartado 10, San Jos&eacute; de las Lajas,    La Habana, Cuba. Correo electr&oacute;nico: <a href="mailto:lesterjosue@censa.edu.cu" target="_blank">lesterjosue@censa.edu.cu</a>    </I></font>      <P>&nbsp;     <P>&nbsp; <hr size="1">     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The development    of a wide-spectrum antiviral drug against pathogenic coronavirus is nowadays    a attractive prospect and may provide an effective first line of defense against    emerging CoV-related diseases. The most attractive target for the design of    anticoronaviral inhibitors is the main protease or 3CL<SUP>PRO</SUP>. Ligand    docking and screening algorithms are now frequently used in the drug-design    process. The aim of this work based on a validation study of scoring functions    is to find a consensus function or to select the scoring function that better    predicts the orientation of the ligand in the pocket binding site, in order    to perform a virtual screening in ligand databases, with a lower computational    cost in the intent of finding a leader compound for antiviral drug against coronaviruses.    For this purpose, the scoring functions were implemented within the Dock4.0    program suite and the 2ALV main protease three dimensional structures will be    used. The protein structure was selected because it was crystallized with a    non-peptidic ligand. The main protease coronavirus pocket including the catalytic    dyad Cys145 His41 was obtained. The closer RSMD media values to 4.0 A<SUP>o</SUP>    were obtained using the contact score function from the rigid ligand dock method.    This score function was selected as the best ranking tool for the search based    on virtual screening of the potential candidate inhibitors of the important    pathogen group belonging to the genus coronavirus. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Key words:</b>    docking algorithms; scoring functions; rigid docking; flexible docking; main    protease; coronavirus</font> <hr size="1">     <P><B></B>     <P><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">RESUMEN</font></b>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">El desarrollo de    f&aacute;rmacos antivirales de amplio espectro que se puedan utilizar contra    diferentes pat&oacute;genos emergentes del g&eacute;nero coronavirus como primera    l&iacute;nea de defensa es hoy una perspectiva atractiva. La proteasa principal    de los coronavirus 3CL<SUP>PRO</SUP> es la diana de mayor atractivo para el    dise&ntilde;o de inhibidores anticoronavirus. Los algoritmos de <I>screening</I>    y <I>docking</I> son actualmente muy utilizados en los procesos de dise&ntilde;o    racional de f&aacute;rmacos. El objetivo de este trabajo es, basados en un estudio    de validaci&oacute;n de las funciones de <I>score</I>, encontrar una funci&oacute;n    consenso o seleccionar la funci&oacute;n de <I>score</I> que mejor prediga la    orientaci&oacute;n del ligando en el bolsillo catal&iacute;tico de la 3CLpro,    con el fin de mejorar las b&uacute;squeda por <I>screening</I> virtual en las    bases de datos de ligandos, compuestos que puedan servir de l&iacute;deres como    candidatos a usarse como f&aacute;rmacos inhibidores anticoronavirus, con un    menor costo computacional. Con este prop&oacute;sito se utilizaron las funciones    de score implentadas en el paquete de programas del DOCK4.0 y la estructura    cristalizada de la 3CLpro 2ALV, esta &uacute;ltima se seleccion&oacute; por    estar cristalizada con un ligando de naturaleza no pept&iacute;dica. Se dise&ntilde;&oacute;    el bolsillo catal&iacute;tico de la proteasa principal de coronavirus que incluy&oacute;    los residuos que conforman la d&iacute;ada catal&iacute;tica Cys145 His41. La    funci&oacute;n con la cual se obtuvieron los mejores valores de RSMD m&aacute;s    cercanos a 4.0A<SUP>o</SUP>, fue la funci&oacute;n de contacto, siguiendo un    algoritmo de orientaci&oacute;n de ligando r&iacute;gido, esta funci&oacute;n    se seleccion&oacute; como la mejor herramienta en la puntuaci&oacute;n de b&uacute;squedas    basadas en <I>screening</I> virtual de candidatos potenciales como inhibidores    del importante grupo de pat&oacute;genos del g&eacute;nero coronavirus.</font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Palabras clave:</b>    algoritmos de docking; funciones de puntuaci&oacute;n; docking r&iacute;gido;    docking flexible; proteasa principal; coronavirus</font> <hr size="1">     <P>&nbsp;     <P>&nbsp;     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>INTRODUCTION    </b></font>     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Coronaviruses (CoVs),    a genus containing about 26 known species to</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">    date, cause highly prevalent diseases in human and animals of veterinary importance    (1,2).The members of this genus are subdivided into three groups based on genetic    and serological markers and nowadays may be considered &quot;emerging pathogens&quot;    (1,3). Coronaviruses are enveloped, plus strand RNA virus with the largest RNA    genome known (on order of 30Kb), the 5' two-thirds of their genome encode a    polyprotein that contains all proteins necessary for RNA replication and 3'    one-third encodes the structural proteins (1). In common with other RNA viruses    employing RNA-dependent RNA polymerase for genome replication, coronaviruses    undergo high rates to mutations and recombination (4,5). Despite the efforts    for developing an effective vaccine for protection against relevant members    of the genus coronaviruses such as, transmissible gastroenteritis virus (TEGV),    infection bronchitis virus (IBV), severe acute respiratory syndrome (SARS),    either live attenuated vaccines, inactive vaccines or subunit vaccines have    been failed, due to, the occurrence of CoV disease at mucosal surfaces, at which,    needs the stimulation of local immunity. Further, high rates to mutations and    recombination of the CoV are often no cross protective for vaccination (6,7,8).    In view of the issue posed above, the development of a wide-spectrum antiviral    drug against pathogenic coronavirus is more reasonable and attractive prospect    and may provide an effective first line of defense against emerging CoV-related    diseases (2). The most attractive target for design of anticoronaviral inhibitors    is the main protease or 3CL<SUP>PRO</SUP>, due to, closely three dimensional    structural conservation among the members of genus, highly conserved substrate    binding site, and important pivotal role play in viral gene expression, replication    and proteolytic processing (2). Ligand docking and screening algorithms are    now frequently used in the drug-design process. The purpose of docking algorithms    is now expanding beyond the original goal of fitting a given ligand into a specific    protein structure. Newer applications include database screening, lead generation    and de novo drug design. A docking procedure consists of three interrelated    components: identification of the binding site, a search algorithm to effectively    sample the search space (the set of possible ligand positions and conformations    on the protein surface) and a scoring function. The number of solved structures    of ligand-protein complexes now available for some targets allows the testing    and validation of docking algorithms, by comparison of complexes predicted by    them with complex ligand-protein extracted from databases (9). The aim of this    work based on a validation study of scoring functions, is to find a consensus    function or to select the scoring function that better predict the orientation    of the ligand in the pocket binding site in order to perform a virtual screening    in ligand databases, with a lower computational cost in the intent of finding    a leader compound for antiviral drug against coronaviruses. For this purpose,    the scoring functions implemented within the <I>Dock 4.0)</I> program suite    and the 2ALV main protease three dimensional structures will be used. The protein    structure was selected because it was crystallized with a non-peptidic ligand.    </font>     <P>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">MATERIALS    AND METHODS </font></B></font><font size="3"><B> </B></font></p> <B>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Pocket generation</font> </B>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The pocket binding    site of the main protease coronavirus was generated from 2ALV available in Protein    Data Bank (PDB), at which it had 1.8 A<SUP>o</SUP> of resolution complex with    CY6 ligand (10,11). The heteroatoms presents in the crystal structure are not    presents in protein native structure, just in the crystal structure gaining    in stability. On the other hand, the B monomer has the same composition and    conformation that A monomer, the 3 CL<SUP>PRO </SUP>is enzymatically active    as monomer and dimer, this feature is important biological role, analyzing the    possible interaction between the A monomer and ligans the B monomer is including,    by this reasons mentioned above the heteroatoms and B monomer were removed using    <I>Chimera Version 1.6</I> program. The ligand and protein were separated in    different files. The maximum distances interaction between ligand and protein    is 5.0 A<SUP>o</SUP> given by the Van der Waals forces (2.5A<SUP>o</SUP> from    ligand and pocket) with the aim to take account the atoms that interacts directly    and indirectly with the ligand the pocket was obtained from <I>GET_NEAR_RES</I>    <I>Version 2.2.2</I> and the residues were involved at 6.0 A<SUP>o </SUP>to    distances from to ligand. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Grid evaluation    </B> </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The grid point    calculation was carried out by a <I>Grid </I>package program included within    <I>Dock (4.0.1)</I>. The parameters were adjusted following the instructions    of the Dock 4.0 manual (12). The critical points are exposed briefly in <a href="/img/revistas/rsa/v30n3/f0103308.jpg" target="_blank">Table    1</a>. The box distance parameters were estimated at 5.0 A<SUP>o</SUP> and grid    spacing parameters at 0.2 A<SUP>o</SUP> (black letters). The other parameters    were accepted from default. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Docking process</B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The orientation    of ligand at the binding site surfaces to the main protease coronavirus was    carried out using the suite package program <I>Dock4.0.</I> The three scoring    functions included within the program were evaluated adjusting the parameters    for rigid and flexible ligand methods. Both methods were computed taken account    the Dock 4.0 manual instructions briefly, the critical parameters were obtained    throughout the pre-screening assays, and the values selected by the best orientation    results (12). The rigid ligand method case, 100 conformational orientations    selected of 500 orientations were ranked, these orientations were generated    throughout the automated search algorithms used to refine affinity estimates    of predicted complexes ligand-protein, a maximum 2 bump filter and contact clash    penalty value to 50. The flexible ligand method was evaluated like the rigid    ligand method critical point parameters, but other parameters needed for this    type of orientations exposed in <a href="/img/revistas/rsa/v30n3/f0203308.jpg" target="_blank">Table    2</a> are included, the other parameters were accepted from default. </font>      
]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Evaluation of    the relation to score values from dock process and RSMD values</b> </font>      <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The values from    dock process using the three different scoring functions of <i>Dock4.0</i> were    tabulated and analyzed using the <i>Statgrafics Version 5.0</i> program.</font>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Statistic Analysis</B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The statistic analysis    for all RSMD values from different scoring functions and both methods to ligand    orientation were made using the<I> SAS version 7.0. </I>program, with a Kruskal-Wallis    method and p&lt;0.05. The values obtained were analyzed individually and were    grouped by scoring functions method for each method and between both methods.    </font>     <P>&nbsp;     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">RESULTS    AND DISCUSION </font></B></font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Pocket binding    site of coronavirus main protease</b></font> <B></B>      <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The main protease    coronavirus pocket defined using <I>GET_NEAR_RES</I> <I>Version 2.2.2</I> program    was obtained. The pocket includes catalytic dyad Cys145 His41, the complementary    catalytic residues Asp187 replace the water molecule within the pocket and form    a catalytic triad (13). Other residues play a role to give stability at tridimensional    conformation pocket structure, and loops associated with the flexibility of    the substrate-binding pocket, such as Phe140, His163, Glu166 and His172 were    included, each one less to 6.0 Ao to distance at substrate, all residues obtained    are show in <a href="/img/revistas/rsa/v30n3/f0303308.jpg" target="_blank">Table    3</a>, and them 3D conformation is shown in <a href="/img/revistas/rsa/v30n3/f0403308.jpg" target="_blank">Figure    1</a>, these residues define the 3CL<SUP>PRO </SUP>pocket (14). </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Grid evaluation</B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Potential energy    grids are used for various docking programs to improve representations and energetic    contributions on grid points so that they only need to be read during ligand    scoring basic idea is to store information about the receptor energetic contribution.    In the most basic form, grid points store two types of potentials: electrostatic    and Van der Waals interactions (Box) (15). <a href="/img/revistas/rsa/v30n3/f0503308.jpg" target="_blank">Figure    2</a> shows a representative grid for electrostatic potentials and steric interactions.    Grid values are shown in <a href="/img/revistas/rsa/v30n3/f0603308.jpg" target="_blank">Table    4</a>. Grid-based tools that allow the identification of cavities on proteins    are available. Among all the cavities accessible on a protein, one of them is    the active site. Several functions have been proposed to molecular mechanic    approaches such as DOCK. </font>      
]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Validation of    scoring functions for coronavirus main protease</B></font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The evaluation    and ranking of predicted ligand conformations are crucial aspects for structure-based    virtual screening (16). The most common mean of estimating a binding affinity    is to use a scoring function, by partitioning the free energy into recognizable    components. The number and type of terms vary between scoring functions, but    in general there are terms for hydrogen bonding, van der Waals, electrostatic    and hydrophobic interactions, and entropy penalties (13). The success of a docking    algorithm in predicting a ligand binding pose is normally measured in terms    of the root-mean-square deviation (RMSD) between the experimentally observed    heavy-atom positions of the ligands and the one(s) predicted by the algorithm    (17). All scoring functions encompassed into Dock4.0 program suite used for    coronavirus main protease were compared using RMSD media values, either rigid    ligand dock method or analyzed ligand flexibility between different functions    within the method and different methods (Figures <a href="/img/revistas/rsa/v30n3/f0703308.jpg">3</a>    and <a href="/img/revistas/rsa/v30n3/f0803308.jpg" target="_blank">4</a>).    </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The closest RSMD    media values to 4.0 A<SUP>o</SUP> were obtained using the contact score function    from the rigid ligand dock method. This scoring function might be used in virtual    screening at ligand database as proposal in the search of potential inhibitor    to coronavirus main protease. The best 10 ligands oriented within pocket binding    site surface of coronavirus main protease are shown in <a href="/img/revistas/rsa/v30n3/f0903308.jpg" target="_blank">Figure    5</a>. In the <a href="/img/revistas/rsa/v30n3/f0903308.jpg" target="_blank">Figure    5</a> is shown that high cavities of the pocket binding site allows that different    conformation of the ligand can be interacts with different protease residues    included within the pocket selected, this propriety will facility to find various    candidates with antiviral activity. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Analysis to    relation of score values and ligand orientation.</B> </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The scoring function    is expressed in terms of free energy, to provide an estimate of the binding    affinity between receptor and ligand molecules (9). The score values obtained    from the evaluation by scoring function Dock4.0 for the orientation of the ligand    within the binding site of coronavirus main protease were plotted against RMSD    individual values of orientation. For the three different scoring functions,    either the rigid ligand method or the flexible one, were used (<a href="/img/revistas/rsa/v30n3/f1003308.jpg" target="_blank">Figure    6</a>). In all cases, a mathematic direct relation between score values and    RMSD values cannot be found. These imperfections in the scoring function continue    to be the major limiting factor. Scoring functions normally used in docking    programs make a number of simplifications and assumptions to allow a more computationally    efficient evaluation of ligand affinity (18). Thus, the implementation of a    consensus function is needed for carrying out a virtual screening at the ligand    databases for coronavirus main protease. </font>      
<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Consensus scoring    combines the information obtained from different scores to compensate errors    from individual scoring functions, therefore improving the probability of finding    the correct solution (19,20). This approach involves obtaining an output list    of dockings with some search engine and primary score functions, and then re-scoring    the final list with various secondary score functions and finally taking the    intersection of a set of re-scored lists. The relationship between the performance    of a given score functions in these two roles remains to be established (21).    In our case a secondary score functions was not found, by this reason was selected    for a posterior studies the contact scoring function, because of, it was with    the best orientation results were obtained. </font>     <P>&nbsp;     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">CONCLUSION</font></B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The docking process    involves the prediction of ligand conformation and orientation within a targeted    binding site. In this work, the scoring functions of Dock4.0 program suite were    validated. The contact score function was selected as the best ranking tool    for the search based on virtual screening of the potential candidate inhibitors    of the important pathogen group belonging to the genus coronavirus. </font>     <P>&nbsp;     ]]></body>
<body><![CDATA[<P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">REFERENCES</font></B>    </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Weiss SR and    Martin SN. Coronavirus pathogenesis and emerging pathogen severe acute respiratory    syndrome coronavirus. Microbiol Mol Biol Rev. 2005; 69(4):635-64. </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Yang H, Xie    W, Xue X, Yang K, Wenxue JM, Zhao LO, et al. Design of Wide-Spectrum Inhibitors    Targeting Coronavirus Main Proteases. <I>PLoS Biol</I>. 2005;3(10):324-36. </font>    <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Stark CJ and    Atreya CD. Molecular advances in the cell biology of SARS-CoV and current diseases    prevention strategies. Virol. J. 2005;2:35-43. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Domingo E and    Holland JJ. A virus mutations and fitness for survival. Annu Rev Microbiol.    1997;51:151-78. </font>     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Rest JS and    Mindell DP. SARS associated coronavirus has a recombinant polymerase and coronaviruses    have a history of hostshifting. Infect Genet Evol<I>.</I> 2003;3:219-25. </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Saif LJ, van    Cott JL, Brim TA. Immunity to transmissible gastroenteritis virus and porcine    respiratory coronavirus infections in swine. Vet. Immunol. Immunopathol<I>.</I>    1994;43:89-97. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Cavanagh D.    Severe acute respiratory syndrome vaccine development: experiences of vaccination    against avian infectious bronchitis coronavirus. Avian Pathology. 2003;32(6):567-82.    </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Saif LJ. Animal    coronavirus vaccines: lessons for SARS<I>. </I>Dev Biol. 2004; 119:129-40. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. McConkey BJ,    Sobolev V, Edelman M. The performance of current methods in ligands-protein    docking. Current Science. 2002;83(7):845-56. </font>    <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.Ghosh AK, Xi    K, Ratia K, Santarsiero BD, Fu W, Harcourt BH, et al. X-ray structural analysis    of SARS coronavirus 3CL proteinase in complex with designed anti-viral inhibitors.    2006; [cited 2007 10 Dec]&#160;available from: <a href="http://www.rcsb.org/pdb/explore.do?structureId=2ALV" target="_blank">http://www.rcsb.org/pdb/explore.do?structureId=2ALV</a>.    </font>      <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.Ghosh, AK, Xi    K, Ratia K, Santarsiero BD, Fu W, Harcourt BH, et al. Design and synthesis of    peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease    inhibitors. J.Med.Chem. 2005;48:6767-71. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.<a href="http://www.dock.compbio.ucsf.edu/Old_Versions%20/Dock4.0_manual.pdf" target="_blank">http://www.dock.compbio.ucsf.edu/Old_Versions    /Dock4.0_manual.pdf</a> </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.Tan J, Verschueren    K, Anand K, Shen J, Yang M, Xu Y, et al. PH-dependent Conformational Flexibility    of the SARS-CoV Main Protease (M<SUP>pro</SUP>) Dimer : Molecular Dynamics Simulation    and Multiple X-Ray Structure Analyses. J.Mol.Biol. 2005;354: 35-40. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.Chou CY, Chang    HC, Hsu WC, Lin TZ, Lin CH, Chang GG. Quaternary structure of the severe acute    respiratory syndrome (SARS) coronavirus main protease. Biochemistry. 2004;43:14958-70.    </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.Kitchen D, Decornez    H, Furr J, Bajorath J. Docking and scoring in virtual screening for drug discover:    Methods and applications. Drug Dicovery. 2004;3: 935-49. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.Simonson T,    Archontis G, Karplus M. Free energy simulations come of age: protein_ligand    recognition. Acc. Chem. Res. 2002&#160;;35:430-37. </font>    <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.Sousa SF, Fern&aacute;ndez    PA, Ramos JM. Protein_Ligand Docking: Current Status and Future Challenges.    Proteins: Structure, Function, and Bioinformatics. 2006;65:15-26. </font>     <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.Taylor RD, Jewsbury    PJ, Essex JW. A review of protein-small molecule docking methods. J Comput Aided    Mol Des. 2002;16:151-66. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19.Charifson PS,    Corkery JJ, Murcko MA, Walters WP. Consensus scoring: a method for obtaining    improved hit rates from docking databases of three-dimensional structures into    proteins. J Med Chem. 1999;42:5100-09. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20.Halperin I,    Ma B, Wolfson H, Nussinov R. Principles of docking: an overview of search algorithms    and a guide to scoring functions. Proteins. 2002;47:409-43. </font>    <!-- ref --><P><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21.Mohan V, Gibbs    AC, Cummings MD, Jaeger EP, DesJarlais RL. Docking: Successes and Challenges.    Current Pharmaceutical Design. 2005;11: 323-33. </font>    <P>&nbsp;     <P>&nbsp;     <P><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>(Recibido 10-1-2008;    Aceptado 22-6-2008)</B></font>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Coronavirus pathogenesis and emerging pathogen severe acute respiratory syndrome coronavirus]]></article-title>
<source><![CDATA[Microbiol Mol Biol Rev]]></source>
<year>2005</year>
<volume>69</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>635-64</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Xue]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wenxue]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[LO]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases]]></article-title>
<source><![CDATA[PLoS Biol]]></source>
<year>2005</year>
<volume>3</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>324-36</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stark]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Atreya]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Molecular advances in the cell biology of SARS-CoV and current diseases prevention strategies]]></article-title>
<source><![CDATA[Virol J]]></source>
<year>2005</year>
<volume>2</volume>
<page-range>35-43</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domingo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A virus mutations and fitness for survival]]></article-title>
<source><![CDATA[Annu Rev Microbiol]]></source>
<year>1997</year>
<volume>51</volume>
<page-range>151-78</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rest]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Mindell]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of hostshifting]]></article-title>
<source><![CDATA[Infect Genet Evol]]></source>
<year>2003</year>
<volume>3</volume>
<page-range>219-25</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saif]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[van Cott]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Brim]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine]]></article-title>
<source><![CDATA[Vet Immunol Immunopathol]]></source>
<year>1994</year>
<volume>43</volume>
<page-range>89-97</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cavanagh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus]]></article-title>
<source><![CDATA[Avian Pathology]]></source>
<year>2003</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>567-82</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saif]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Animal coronavirus vaccines: lessons for SARS]]></article-title>
<source><![CDATA[Dev Biol]]></source>
<year>2004</year>
<volume>119</volume>
<page-range>129-40</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McConkey]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sobolev]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Edelman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The performance of current methods in ligands-protein docking]]></article-title>
<source><![CDATA[Current Science]]></source>
<year>2002</year>
<volume>83</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>845-56</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghosh]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Xi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ratia]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Santarsiero]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Harcourt]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
</person-group>
<source><![CDATA[X-ray structural analysis of SARS coronavirus 3CL proteinase in complex with designed anti-viral inhibitors]]></source>
<year>2006</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghosh]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Xi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ratia]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Santarsiero]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Fu]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Harcourt]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors]]></article-title>
<source><![CDATA[J Med Chem]]></source>
<year>2005</year>
<volume>48</volume>
<page-range>6767-71</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Verschueren]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Anand]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[PH-dependent Conformational Flexibility of the SARS-CoV Main Protease (Mpro) Dimer: Molecular Dynamics Simulation and Multiple X-Ray Structure Analyses]]></article-title>
<source><![CDATA[J Mol Biol]]></source>
<year>2005</year>
<volume>354</volume>
<page-range>35-40</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chou]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[TZ]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease]]></article-title>
<source><![CDATA[Biochemistry]]></source>
<year>2004</year>
<volume>43</volume>
<page-range>14958-70</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kitchen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Decornez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Furr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bajorath]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Docking and scoring in virtual screening for drug discover: Methods and applications]]></article-title>
<source><![CDATA[Drug Dicovery]]></source>
<year>2004</year>
<volume>3</volume>
<page-range>935-49</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simonson]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Archontis]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Karplus]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Free energy simulations come of age: protein_ligand recognition]]></article-title>
<source><![CDATA[Acc Chem Res]]></source>
<year>2002</year>
<volume>35</volume>
<page-range>430-37</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Protein Ligand Docking: Current Status and Future Challenges]]></article-title>
<source><![CDATA[Proteins: Structure, Function, and Bioinformatics]]></source>
<year>2006</year>
<volume>65</volume>
<page-range>15-16</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Jewsbury]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Essex]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A review of protein-small molecule docking methods]]></article-title>
<source><![CDATA[J Comput Aided Mol Des]]></source>
<year>2002</year>
<volume>16</volume>
<page-range>151-66</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Charifson]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Corkery]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Murcko]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Walters]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins]]></article-title>
<source><![CDATA[J Med Chem]]></source>
<year>1999</year>
<volume>42</volume>
<page-range>5100-09</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halperin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nussinov]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Principles of docking: an overview of search algorithms and a guide to scoring functions]]></article-title>
<source><![CDATA[Proteins.]]></source>
<year>2002</year>
<volume>47</volume>
<page-range>409-43</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbs]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Jaeger]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[DesJarlais]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Docking: Successes and Challenges]]></article-title>
<source><![CDATA[Current Pharmaceutical Design]]></source>
<year>2005</year>
<volume>11</volume>
<page-range>323-33</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
